Hematology and Cell Therapy, 1432-0584

Journal

More filtering options
  1. 2019
  2. Direct comparison of two extended-half-life recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia A

    Anita Shah, Alexander Solms, Sara Wiegmann, Maurice Ahsman, Erik Berntorp, Andreas Tiede, Alfonso Iorio, Maria Elisa Mancuso, Tihomir Zhivkov & Toshko Lissitchkov, 2019, In : Annals of Hematology. 98, 9, p. 2035-2044

    Research output: Contribution to journalArticle

  3. 2018
  4. Internal tandem duplication mutations in the tyrosine kinase domain of FLT3 display a higher oncogenic potential than the activation loop D835Y mutation

    Alissa Marhäll, Florian Heidel, Thomas Fischer & Lars Rönnstrand, 2018, In : Annals of Hematology. 97, 5, p. 773-780

    Research output: Contribution to journalArticle

  5. Low-virulent Babesia venatorum infection masquerading as hemophagocytic syndrome

    Jonas Bläckberg, Vladimir Lj Lazarevic, Klaus Peter Hunfeld & Kristina E.M. Persson, 2018, In : Annals of Hematology. 97, 4, p. 731-733

    Research output: Contribution to journalLetter

  6. 2012
  7. 3,4-Diarylmaleimides-a novel class of kinase inhibitors-effectively induce apoptosis in FLT3-ITD-dependent cells

    Florian H. Heidel, Thomas S. Mack, Elena Razumovskaya, Marie-Christine Blum, Daniel B. Lipka, Anne Ballaschk, Jan-Peter Kramb, Stanislav Plutizki, Lars Rönnstrand, Gerd Dannhardt & Thomas Fischer, 2012, In : Annals of Hematology. 91, 3, p. 331-344

    Research output: Contribution to journalArticle

  8. Metabolic factors and blood cancers among 578,000 adults in the metabolic syndrome and cancer project (Me-Can)

    Gabriele Nagel, Tanja Stocks, Daniela Spaeth, Anette Hjartaker, Bjorn Lindkvist, Goran Hallmans, Hakan Jonsson, Tone Bjorge, Jonas Manjer, Christel Haggstrom, Anders Engeland, Hanno Ulmer, Randi Selmer, Hans Concin, Paer Stattin & Richard F. Schlenk, 2012, In : Annals of Hematology. 91, 10, p. 1519-1531

    Research output: Contribution to journalArticle

  9. 2010
  10. Animal models of immune thrombocytopenia (ITP)

    John W Semple, 2010 Jul, In : Annals of Hematology. 89 , Suppl 1, p. 37-44 8 p.

    Research output: Contribution to journalArticle

  11. Future research in ITP: an ICIS consensus

    James L Zehnder, John W Semple, Paul Imbach, Ellis J Neufeld, George R Buchanan, Douglas B Cines & ICIS Study Group on Future Research in ITP ICIS Study Group on Future Research in ITP, 2010 Jul, In : Annals of Hematology. 89, Suppl 1, p. 19-23 5 p.

    Research output: Contribution to journalArticle

  12. 2004
  13. A novel chromosomal translocation t(3;7)(q26;q21) in myeloid leukemia resulting in overexpression of EVI1

    CT Storlazzi, L Anelli, F Albano, A Zagaria, M Ventura, M Rocchi, Ioannis Panagopoulos, A Pannunzio, E Ottaviani, V Liso & G Specchia, 2004, In : Annals of Hematology. 83, 2, p. 78-83

    Research output: Contribution to journalArticle

  14. Assessment of biological prognostic factors provides clinically relevant information in patients with diffuse large B-cell lymphoma-a Nordic Lymphoma Group study.

    Mats Jerkeman, Harald Anderson, Michael Dictor, S. Kvaløy, Måns Åkerman & Eva Cavallin-Ståhl, 2004, In : Annals of Hematology. 83, 7, p. 414-419

    Research output: Contribution to journalArticle

  15. 1996
  16. Resistance to activated protein C, the FV:Q506 allele, and venous thrombosis

    Björn Dahlbäck, A. Hillarp, S. Rosen & Bengt Zöller, 1996 Apr, In : Annals of Hematology. 72, 4, p. 166-176 11 p.

    Research output: Contribution to journalReview article